What You Should Know
The News: Cellares has raised $257M in Series D financing, bringing its total capital to $612 million. The round was co-led by BlackRock and Eclipse.The Tech: Cellares is building the world’s…
Continue Reading
Ivan Wall, the director of Resilience and a professor of regenerative medicine at the University of Birmingham. Pic credit: Resilience
A £4.3 million UK government scheme is aiming to inspire more than 140,000 people…
Continue Reading
Converge Bio Team
What You Should Know
– Converge Bio has announced a $25M Series A funding round led by Bessemer Venture Partners, bringing its total raised to $30M.
– Moving beyond the “AI promise” gap, the…
Continue Reading
What You Should Know
– NVIDIA and Eli Lilly and Company have announced a historic $1B, five-year investment to launch an AI co-innovation lab in the San Francisco Bay Area.
– Utilizing the NVIDIA BioNeMo platform…
Continue Reading
What You Should Know
– ProPublica has released Rx Inspector, a first-of-its-kind database that allows Americans to identify the exact facility where their generic prescriptions were manufactured.
– By connecting disparate FDA databases and suing for…
Continue Reading
Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and possibly at less expense.Pharma first started using artificial intelligence in the clinical and development…
Continue Reading
Introduction to Japan’s Evolving Competition Landscape
Japan’s competition law framework is undergoing significant transformation under new leadership at the Fair Trade Commission. In May 2025, Mr. Eiji Chatani assumed the role of JFTC Chair, bringing…
What You Should Know:
– Vyriad, Inc. has secured the final $25M of its Series B financing, bringing the total round to $85M led by Mr. Harry Stine of Stine Seed Farms, Inc.
– The…
Continue Reading
Erik Terjesen, Managing Director, Silicon Foundry, a Kearney Company
Drug shortages have surged to their highest levels in decades. In early 2024, U.S. pharmacies reported more than 323 active shortages, spanning essential generics, injectables, and…
Continue Reading
Nvidia’s Strategic AI Acquisition
Nvidia announced on Monday its acquisition of SchedMD, a leading AI software company, marking a significant strategic move to strengthen its position in the rapidly evolving artificial intelligence landscape. This acquisition…
